+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stomach Cancer Drug"

From
Gastric Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Gastric Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Global Gastric Cancer Drugs Market 2023-2027 - Product Thumbnail Image

Global Gastric Cancer Drugs Market 2023-2027

  • Report
  • July 2023
  • 160 Pages
  • Global
From
From
HER+ Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER+ Gastric Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HER2-positive Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2-positive Gastric Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
From
From
From
Loading Indicator

Stomach cancer, also known as gastric cancer, is a type of cancer that affects the lining of the stomach. Oncology drugs are used to treat this type of cancer, and the stomach cancer drug market is a subset of the larger oncology drug market. These drugs are used to treat both early and advanced stages of stomach cancer, and can be administered orally, intravenously, or through injections. They can also be used in combination with other treatments such as chemotherapy and radiation therapy. The stomach cancer drug market is highly competitive, with many companies developing and marketing drugs for the treatment of this type of cancer. Some of the major players in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to improve the treatment of stomach cancer. Show Less Read more